|Articles|December 8, 2011
Video blog: BOLERO-2 and Afinitor in breast cancer
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the updated results of the BOLERO-2 study, which looked at Afinitor (everolimus) and an aromatase inhibitor in metastatic breast cancer. How useful will this new drug be in metastatic breast cancer?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
"You Think It Won't Happen to You" — Teddi Mellencamp on Melanoma and Speaking Up
2
A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia
3
Living with Metastatic Cancer Means Loss in the Midst of Love
4
ZUSDURI and the ENVISION Trial: A Non-Surgical Path Forward for Recurrent Bladder Cancer
5